Literature DB >> 15145702

Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.

Aleksandra Bulka1, Poli Francois Kouya, Ylva Böttiger, Jan-Olof Svensson, Xiao-Jun Xu, Zsuzsanna Wiesenfeld-Hallin.   

Abstract

Sprague-Dawley rats from two different vendors, Möllegård, Denmark and B&K Universal, Sweden, have been tested for the antinociceptive effect of morphine, methadone, buprenorphine and codeine on the hot plate. Morphine and methadone had significantly weaker effect in Möllegård rats compare to B&K rats. In contrast, the effect of buprenorphine was stronger in Möllegård rats than in B&K rats and the effect of codeine was similar in the two substrains. Plasma levels of morphine, morphine-6-glucuronide, morphine-3-glucuronide, buprenorphine and norbuprenorphine were determined at two time points after drug injection. Möllegård rats had significantly lower mean plasma level of morphine and significantly higher ratio of morphine-3-glucuronide/morphine at 30 min, compared to B&K rats. No difference was seen for the metabolism of buprenorphine in the two substrains. The results suggest that Möllegård rats metabolize morphine to morphine-3-glucuronide to a greater extent than B&K rats, and this may at least partly underlie the substrain difference in the effect of morphine. It is also suggested that the antinociceptive mechanisms of buprenorphne may be different from those of morphine and methadone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145702     DOI: 10.1016/j.ejphar.2004.03.041

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Probuphine® (buprenorphine implant): a promising candidate in opioid dependence.

Authors:  Preeti Barnwal; Saibal Das; Somnath Mondal; Anand Ramasamy; Tanay Maiti; Arunava Saha
Journal:  Ther Adv Psychopharmacol       Date:  2016-12-19

Review 2.  Buprenorphine in cancer pain.

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

3.  Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain.

Authors:  Khalid Benamar; Jonathan Palma; Alan Cowan; Ellen B Geller; Martin W Adler
Journal:  Drug Alcohol Depend       Date:  2010-11-26       Impact factor: 4.492

4.  HIV-gp120 and physical dependence to buprenorphine.

Authors:  J Palma; M E Abood; K Benamar
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

5.  Changes in fentanyl demand following naltrexone, morphine, and buprenorphine in male rats.

Authors:  Lindsey R Hammerslag; Rebecca S Hofford; Qiwen Kang; Richard J Kryscio; Joshua S Beckmann; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2019-12-16       Impact factor: 4.492

6.  Transfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward.

Authors:  Nicolas Marie; Corinne Canestrelli; Florence Noble
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Subcutaneous Implants of a Cholesterol-Triglyceride-Buprenorphine Suspension in Rats.

Authors:  M Guarnieri; C Brayton; R Sarabia-Estrada; B Tyler; P McKnight; L DeTolla
Journal:  J Vet Med       Date:  2017-04-09

8.  The analgesic efficacy of morphine varies with rat strain and experimental pain model: implications for target validation efforts in pain drug discovery.

Authors:  Sara Hestehave; Klas S P Abelson; Tina Brønnum Pedersen; Gordon Munro
Journal:  Eur J Pain       Date:  2018-11-09       Impact factor: 3.931

9.  Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain.

Authors:  Wojciech Leppert; Grzegorz Kowalski
Journal:  Onco Targets Ther       Date:  2015-12-04       Impact factor: 4.147

10.  Comparing the Antinociceptive Effects of Methamphetamine, Buprenorphine, or Both After Chronic Treatment and Withdrawal in Male Rats.

Authors:  Farshid Etaee; Arezoo Rezvani-Kamran; Mohammad Taheri; Ghazaleh Omidi; Parisa Hasanein; Alireza Komaki
Journal:  Basic Clin Neurosci       Date:  2019-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.